MYRTLE BEACH, S.C. (WBTW) — The Federal Trade Commission (FTC) sent a warning letter to a Myrtle Beach business regarding “unsubstantiated claims about coronavirus prevention or treatment.”
The letter was sent to AwareMed on Oleander Drive on April 17. A location for Tennessee was also listed.
The letter states the FTC reviewed the AwareMed website on April 15 and determined the company was “unlawfully advertising that certain products treat or prevent” COVID-19. The letter mentions claims such as an intravenous treatment is a “prevention treatment fronting this pandemia [sic] of #covid19” and “IV Treatments will help to combat the virus.”
Advertising that a product can prevent, treat, or cure human disease without reliable scientific evidence is unlawful under FTC Act 15.
The FTC directed AwareMed to stop making the claims immediately and was given 48 hours to respond with what actions were taken to address the concerns.
FTC Assistant Regional Director for the Southwest Region gave News13 the following statement:
While I cannot provide the specific actions that you seek, what I can say is that the website has been corrected and that the challenged claims have been removed.
Read the full letter below:
News13 reached out to the business on Thursday evening and is awaiting a response. Count on News13 for updates.
